Rischin D, Hughes BGM, Basset-Séguin N, et al. High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma. J Immunother Cancer 2024;12:e008325. doi: 10.1136/jitc-2023-008325

In this article, the author Axel Hauschild was incorrectly listed as Axel Hausschild.